Literature DB >> 26572145

Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment.

Chen Zu1, Biao Jie1,2, Mingxia Liu1, Songcan Chen1, Dinggang Shen3,4, Daoqiang Zhang5.   

Abstract

Multimodal classification methods using different modalities of imaging and non-imaging data have recently shown great advantages over traditional single-modality-based ones for diagnosis and prognosis of Alzheimer's disease (AD), as well as its prodromal stage, i.e., mild cognitive impairment (MCI). However, to the best of our knowledge, most existing methods focus on mining the relationship across multiple modalities of the same subjects, while ignoring the potentially useful relationship across different subjects. Accordingly, in this paper, we propose a novel learning method for multimodal classification of AD/MCI, by fully exploring the relationships across both modalities and subjects. Specifically, our proposed method includes two subsequent components, i.e., label-aligned multi-task feature selection and multimodal classification. In the first step, the feature selection learning from multiple modalities are treated as different learning tasks and a group sparsity regularizer is imposed to jointly select a subset of relevant features. Furthermore, to utilize the discriminative information among labeled subjects, a new label-aligned regularization term is added into the objective function of standard multi-task feature selection, where label-alignment means that all multi-modality subjects with the same class labels should be closer in the new feature-reduced space. In the second step, a multi-kernel support vector machine (SVM) is adopted to fuse the selected features from multi-modality data for final classification. To validate our method, we perform experiments on the Alzheimer's Disease Neuroimaging Initiative (ADNI) database using baseline MRI and FDG-PET imaging data. The experimental results demonstrate that our proposed method achieves better classification performance compared with several state-of-the-art methods for multimodal classification of AD/MCI.

Entities:  

Keywords:  Alzheimer’s disease; Feature selection; Label alignment; Mild cognitive impairment; Multi-task learning; Multimodal classification

Mesh:

Substances:

Year:  2016        PMID: 26572145      PMCID: PMC4868803          DOI: 10.1007/s11682-015-9480-7

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  45 in total

1.  Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

Authors:  G Chételat; B Desgranges; V de la Sayette; F Viader; F Eustache; J-C Baron
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

2.  Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity.

Authors:  Stéphane P Poulin; Rebecca Dautoff; John C Morris; Lisa Feldman Barrett; Bradford C Dickerson
Journal:  Psychiatry Res       Date:  2011-09-14       Impact factor: 3.222

3.  Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population.

Authors:  Chris Hinrichs; Vikas Singh; Guofan Xu; Sterling C Johnson
Journal:  Neuroimage       Date:  2010-12-10       Impact factor: 6.556

4.  Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.

Authors:  An-Tao Du; Norbert Schuff; Joel H Kramer; Howard J Rosen; Maria Luisa Gorno-Tempini; Katherine Rankin; Bruce L Miller; Michael W Weiner
Journal:  Brain       Date:  2007-03-12       Impact factor: 13.501

5.  Inter-modality relationship constrained multi-modality multi-task feature selection for Alzheimer's Disease and mild cognitive impairment identification.

Authors:  Feng Liu; Chong-Yaw Wee; Huafu Chen; Dinggang Shen
Journal:  Neuroimage       Date:  2013-09-14       Impact factor: 6.556

6.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

7.  Longitudinal changes of CSF biomarkers in memory clinic patients.

Authors:  F H Bouwman; W M van der Flier; N S M Schoonenboom; E J van Elk; A Kok; F Rijmen; M A Blankenstein; P Scheltens
Journal:  Neurology       Date:  2007-09-04       Impact factor: 9.910

8.  Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment.

Authors:  Linda K McEvoy; Christine Fennema-Notestine; J Cooper Roddey; Donald J Hagler; Dominic Holland; David S Karow; Christopher J Pung; James B Brewer; Anders M Dale
Journal:  Radiology       Date:  2009-02-06       Impact factor: 11.105

9.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

Authors:  Norman L Foster; Judith L Heidebrink; Christopher M Clark; William J Jagust; Steven E Arnold; Nancy R Barbas; Charles S DeCarli; R Scott Turner; Robert A Koeppe; Roger Higdon; Satoshi Minoshima
Journal:  Brain       Date:  2007-08-18       Impact factor: 13.501

10.  Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging.

Authors:  Emilie Gerardin; Gaël Chételat; Marie Chupin; Rémi Cuingnet; Béatrice Desgranges; Ho-Sung Kim; Marc Niethammer; Bruno Dubois; Stéphane Lehéricy; Line Garnero; Francis Eustache; Olivier Colliot
Journal:  Neuroimage       Date:  2009-05-20       Impact factor: 6.556

View more
  22 in total

1.  Discovering network phenotype between genetic risk factors and disease status via diagnosis-aligned multi-modality regression method in Alzheimer's disease.

Authors:  Meiling Wang; Xiaoke Hao; Jiashuang Huang; Wei Shao; Daoqiang Zhang
Journal:  Bioinformatics       Date:  2019-06-01       Impact factor: 6.937

Review 2.  Machine learning studies on major brain diseases: 5-year trends of 2014-2018.

Authors:  Koji Sakai; Kei Yamada
Journal:  Jpn J Radiol       Date:  2018-11-29       Impact factor: 2.374

Review 3.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

4.  Multi-modal neuroimaging feature selection with consistent metric constraint for diagnosis of Alzheimer's disease.

Authors:  Xiaoke Hao; Yongjin Bao; Yingchun Guo; Ming Yu; Daoqiang Zhang; Shannon L Risacher; Andrew J Saykin; Xiaohui Yao; Li Shen
Journal:  Med Image Anal       Date:  2019-12-02       Impact factor: 8.545

5.  Patch-Based Label Fusion with Structured Discriminant Embedding for Hippocampus Segmentation.

Authors:  Yan Wang; Guangkai Ma; Xi Wu; Jiliu Zhou
Journal:  Neuroinformatics       Date:  2018-10

6.  A Deep Learning Approach for Automated Diagnosis and Multi-Class Classification of Alzheimer's Disease Stages Using Resting-State fMRI and Residual Neural Networks.

Authors:  Farheen Ramzan; Muhammad Usman Ghani Khan; Asim Rehmat; Sajid Iqbal; Tanzila Saba; Amjad Rehman; Zahid Mehmood
Journal:  J Med Syst       Date:  2019-12-18       Impact factor: 4.460

Review 7.  A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages.

Authors:  Saima Rathore; Mohamad Habes; Muhammad Aksam Iftikhar; Amanda Shacklett; Christos Davatzikos
Journal:  Neuroimage       Date:  2017-04-13       Impact factor: 6.556

8.  Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials.

Authors:  Adam M Staffaroni; Peter A Ljubenkov; John Kornak; Yann Cobigo; Samir Datta; Gabe Marx; Samantha M Walters; Kevin Chiang; Nick Olney; Fanny M Elahi; David S Knopman; Bradford C Dickerson; Bradley F Boeve; Maria Luisa Gorno-Tempini; Salvatore Spina; Lea T Grinberg; William W Seeley; Bruce L Miller; Joel H Kramer; Adam L Boxer; Howard J Rosen
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

9.  The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1.

Authors:  Qi Wang; Lei Guo; Paul M Thompson; Clifford R Jack; Hiroko Dodge; Liang Zhan; Jiayu Zhou
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 10.  Single subject prediction of brain disorders in neuroimaging: Promises and pitfalls.

Authors:  Mohammad R Arbabshirani; Sergey Plis; Jing Sui; Vince D Calhoun
Journal:  Neuroimage       Date:  2016-03-21       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.